Does the polymorphism of cytochrome P-450 2E1 affect the metabolism of N,N-dimethylformamide? Comparison of the half-lives of urinary N-methylformamide

Tetsuo Nomiyama, Hiroshi Nakashima, Yuri Sano, Li Ling Chen, Shigeru Tanaka, Hiroyuki Miyauchi, Tsuneyuki Yamauchi, Haruhiko Sakurai, Kazuyuki Omae

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The aim of this study was to clarify whether phenotypic variation exists when subjects with different genotypes of cytochrome P450 2E1 (CYP2E1) are exposed to N,N-dimethylformamide (DMF). The genotypes of CYP2E1 were confirmed in 123 healthy male volunteer subjects. Of the 123 subjects, the numbers of c1 homozygotes, c2 heterozygotes, and c2 homozygotes were 77, 45, and 1, respectively. Seven of the c1 homozygotes, five of the c2 heterozygotes, and the one c2 homozygote (mean age: 22.7 years, range: 20-27 years) were exposed to DMF vapor twice, once via the skin and once via the lung, for a total of 8 h per subject at a concentration below 10 ppm, the occupational exposure limit recommended by the Japan Society for Occupational Health, the American Conference of Governmental and Industrial Hygienists, and Deutsche Forschungsgemeinschaft, at 27°C and 44% relative humidity. Exposure levels were 6.2 ± 1.0 ppm in dermal exposure and 7.1 ± 1.0 ppm in inhalation exposure. Urine samples were collected until 72 h after exposure. The half-lives of urinary N-methylformamide (NMF) were obtained as the phenotype. The average urinary NMF half-lives of the c1 homozygotes, the c2 heterozygotes, and the c2 homozygote were 3.86 ± 1.90, 4.38 ± 1.53, and 4.2 h after dermal exposure, and 1.58 ± 0.42, 1.84 ± 0.61, and 3.2 h after respiratory exposure. The NMF half-lives of the c1 homozygotes were not significantly different from those of the c2 heterozygotes, and there were no differences between the NMF half-lives on the subjects with and without the c2 allele. Even though the data were obtained from only one c2 homozygote, it is noteworthy that the NMF half-life of this subject was slightly less than that of the c1 homozygotes after respiratory exposure.

Original languageEnglish
Pages (from-to)755-759
Number of pages5
JournalArchives of Toxicology
Volume74
Issue number12
DOIs
Publication statusPublished - 2001

Fingerprint

methylformamide
Dimethylformamide
Homozygote
Polymorphism
Metabolism
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP2E1
Heterozygote
Skin
Atmospheric humidity
Genotype
Vapors
Health
Inhalation Exposure
Occupational Health
Occupational Exposure
Humidity

Keywords

  • Cytochrome
  • Genetic polymorphism
  • Genotype
  • N,N-Dimethylformamide
  • P450 2E1
  • Phenotype

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Does the polymorphism of cytochrome P-450 2E1 affect the metabolism of N,N-dimethylformamide? Comparison of the half-lives of urinary N-methylformamide. / Nomiyama, Tetsuo; Nakashima, Hiroshi; Sano, Yuri; Chen, Li Ling; Tanaka, Shigeru; Miyauchi, Hiroyuki; Yamauchi, Tsuneyuki; Sakurai, Haruhiko; Omae, Kazuyuki.

In: Archives of Toxicology, Vol. 74, No. 12, 2001, p. 755-759.

Research output: Contribution to journalArticle

Nomiyama, T, Nakashima, H, Sano, Y, Chen, LL, Tanaka, S, Miyauchi, H, Yamauchi, T, Sakurai, H & Omae, K 2001, 'Does the polymorphism of cytochrome P-450 2E1 affect the metabolism of N,N-dimethylformamide? Comparison of the half-lives of urinary N-methylformamide', Archives of Toxicology, vol. 74, no. 12, pp. 755-759. https://doi.org/10.1007/s002040000197
Nomiyama, Tetsuo ; Nakashima, Hiroshi ; Sano, Yuri ; Chen, Li Ling ; Tanaka, Shigeru ; Miyauchi, Hiroyuki ; Yamauchi, Tsuneyuki ; Sakurai, Haruhiko ; Omae, Kazuyuki. / Does the polymorphism of cytochrome P-450 2E1 affect the metabolism of N,N-dimethylformamide? Comparison of the half-lives of urinary N-methylformamide. In: Archives of Toxicology. 2001 ; Vol. 74, No. 12. pp. 755-759.
@article{38adf62d79cd4c5b896e2f04dec1a269,
title = "Does the polymorphism of cytochrome P-450 2E1 affect the metabolism of N,N-dimethylformamide? Comparison of the half-lives of urinary N-methylformamide",
abstract = "The aim of this study was to clarify whether phenotypic variation exists when subjects with different genotypes of cytochrome P450 2E1 (CYP2E1) are exposed to N,N-dimethylformamide (DMF). The genotypes of CYP2E1 were confirmed in 123 healthy male volunteer subjects. Of the 123 subjects, the numbers of c1 homozygotes, c2 heterozygotes, and c2 homozygotes were 77, 45, and 1, respectively. Seven of the c1 homozygotes, five of the c2 heterozygotes, and the one c2 homozygote (mean age: 22.7 years, range: 20-27 years) were exposed to DMF vapor twice, once via the skin and once via the lung, for a total of 8 h per subject at a concentration below 10 ppm, the occupational exposure limit recommended by the Japan Society for Occupational Health, the American Conference of Governmental and Industrial Hygienists, and Deutsche Forschungsgemeinschaft, at 27°C and 44{\%} relative humidity. Exposure levels were 6.2 ± 1.0 ppm in dermal exposure and 7.1 ± 1.0 ppm in inhalation exposure. Urine samples were collected until 72 h after exposure. The half-lives of urinary N-methylformamide (NMF) were obtained as the phenotype. The average urinary NMF half-lives of the c1 homozygotes, the c2 heterozygotes, and the c2 homozygote were 3.86 ± 1.90, 4.38 ± 1.53, and 4.2 h after dermal exposure, and 1.58 ± 0.42, 1.84 ± 0.61, and 3.2 h after respiratory exposure. The NMF half-lives of the c1 homozygotes were not significantly different from those of the c2 heterozygotes, and there were no differences between the NMF half-lives on the subjects with and without the c2 allele. Even though the data were obtained from only one c2 homozygote, it is noteworthy that the NMF half-life of this subject was slightly less than that of the c1 homozygotes after respiratory exposure.",
keywords = "Cytochrome, Genetic polymorphism, Genotype, N,N-Dimethylformamide, P450 2E1, Phenotype",
author = "Tetsuo Nomiyama and Hiroshi Nakashima and Yuri Sano and Chen, {Li Ling} and Shigeru Tanaka and Hiroyuki Miyauchi and Tsuneyuki Yamauchi and Haruhiko Sakurai and Kazuyuki Omae",
year = "2001",
doi = "10.1007/s002040000197",
language = "English",
volume = "74",
pages = "755--759",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Does the polymorphism of cytochrome P-450 2E1 affect the metabolism of N,N-dimethylformamide? Comparison of the half-lives of urinary N-methylformamide

AU - Nomiyama, Tetsuo

AU - Nakashima, Hiroshi

AU - Sano, Yuri

AU - Chen, Li Ling

AU - Tanaka, Shigeru

AU - Miyauchi, Hiroyuki

AU - Yamauchi, Tsuneyuki

AU - Sakurai, Haruhiko

AU - Omae, Kazuyuki

PY - 2001

Y1 - 2001

N2 - The aim of this study was to clarify whether phenotypic variation exists when subjects with different genotypes of cytochrome P450 2E1 (CYP2E1) are exposed to N,N-dimethylformamide (DMF). The genotypes of CYP2E1 were confirmed in 123 healthy male volunteer subjects. Of the 123 subjects, the numbers of c1 homozygotes, c2 heterozygotes, and c2 homozygotes were 77, 45, and 1, respectively. Seven of the c1 homozygotes, five of the c2 heterozygotes, and the one c2 homozygote (mean age: 22.7 years, range: 20-27 years) were exposed to DMF vapor twice, once via the skin and once via the lung, for a total of 8 h per subject at a concentration below 10 ppm, the occupational exposure limit recommended by the Japan Society for Occupational Health, the American Conference of Governmental and Industrial Hygienists, and Deutsche Forschungsgemeinschaft, at 27°C and 44% relative humidity. Exposure levels were 6.2 ± 1.0 ppm in dermal exposure and 7.1 ± 1.0 ppm in inhalation exposure. Urine samples were collected until 72 h after exposure. The half-lives of urinary N-methylformamide (NMF) were obtained as the phenotype. The average urinary NMF half-lives of the c1 homozygotes, the c2 heterozygotes, and the c2 homozygote were 3.86 ± 1.90, 4.38 ± 1.53, and 4.2 h after dermal exposure, and 1.58 ± 0.42, 1.84 ± 0.61, and 3.2 h after respiratory exposure. The NMF half-lives of the c1 homozygotes were not significantly different from those of the c2 heterozygotes, and there were no differences between the NMF half-lives on the subjects with and without the c2 allele. Even though the data were obtained from only one c2 homozygote, it is noteworthy that the NMF half-life of this subject was slightly less than that of the c1 homozygotes after respiratory exposure.

AB - The aim of this study was to clarify whether phenotypic variation exists when subjects with different genotypes of cytochrome P450 2E1 (CYP2E1) are exposed to N,N-dimethylformamide (DMF). The genotypes of CYP2E1 were confirmed in 123 healthy male volunteer subjects. Of the 123 subjects, the numbers of c1 homozygotes, c2 heterozygotes, and c2 homozygotes were 77, 45, and 1, respectively. Seven of the c1 homozygotes, five of the c2 heterozygotes, and the one c2 homozygote (mean age: 22.7 years, range: 20-27 years) were exposed to DMF vapor twice, once via the skin and once via the lung, for a total of 8 h per subject at a concentration below 10 ppm, the occupational exposure limit recommended by the Japan Society for Occupational Health, the American Conference of Governmental and Industrial Hygienists, and Deutsche Forschungsgemeinschaft, at 27°C and 44% relative humidity. Exposure levels were 6.2 ± 1.0 ppm in dermal exposure and 7.1 ± 1.0 ppm in inhalation exposure. Urine samples were collected until 72 h after exposure. The half-lives of urinary N-methylformamide (NMF) were obtained as the phenotype. The average urinary NMF half-lives of the c1 homozygotes, the c2 heterozygotes, and the c2 homozygote were 3.86 ± 1.90, 4.38 ± 1.53, and 4.2 h after dermal exposure, and 1.58 ± 0.42, 1.84 ± 0.61, and 3.2 h after respiratory exposure. The NMF half-lives of the c1 homozygotes were not significantly different from those of the c2 heterozygotes, and there were no differences between the NMF half-lives on the subjects with and without the c2 allele. Even though the data were obtained from only one c2 homozygote, it is noteworthy that the NMF half-life of this subject was slightly less than that of the c1 homozygotes after respiratory exposure.

KW - Cytochrome

KW - Genetic polymorphism

KW - Genotype

KW - N,N-Dimethylformamide

KW - P450 2E1

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=0034467648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034467648&partnerID=8YFLogxK

U2 - 10.1007/s002040000197

DO - 10.1007/s002040000197

M3 - Article

VL - 74

SP - 755

EP - 759

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

IS - 12

ER -